{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial of a Holistic Approach to Atherosclerosis Management"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "randomly assigned to either a multidisciplinary team-led holistic care model or standard care. Randomisation was computer-generated, and allocation was concealed using sealed envelopes."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were adults with risk factors for atherosclerosis, recruited from multiple healthcare centers."
      },
      "Intervention": {
        "score": 2,
        "evidence": "The intervention group received comprehensive vascular assessments and multidisciplinary care, while the control group received standard care."
      },
      "Objective": {
        "score": 1,
        "evidence": "To assess the effectiveness of a holistic approach in improving vascular health outcomes."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the reduction in cardiovascular events over a 12-month period."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed using sealed envelopes."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to outcome assessors."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 200 participants were randomised, with 100 in each group."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was conducted on 98 participants in the intervention group and 97 in the control group using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The intervention group showed a significant reduction in cardiovascular events (mean difference = 5.2 events, 95% CI 3.1 to 7.3; p = 0.01)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were mild and occurred in 3% of the intervention group and 1% of the control group."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT12345678."
      },
      "Funding": {
        "score": 1,
        "evidence": "This trial was funded by the National Institutes of Health."
      }
    },
    "total_score": 22,
    "max_score": 25
  },
  "model": "gpt-4o"
}